Staff

	Amy Efantis President & CEO
Global Initiatives
John Delacourt Chief Legal Officer and Vice President, Global Initiatives	Larisa Cervenakova Medical Director	George Schreiber Director Epidemiology
Brenna Raines Assistant Director Global Health Policy	Abigail Glaser Administrative Assistant
Source & International Affairs
Joshua Penrod Senior Vice President Source & International Affairs	Sonia Balboni Director Source & Standards	Alexa Wetzel Director Source Europe
Julia Fabens Assistant Director International Affairs	Brenda Norman Senior Manager Data	Diana Krueger Manager IQPP Audits
	Bobbi Stackman Coordinator Source & International Affairs
Regulatory & Quality Policy
Mary Gustafson Vice President Global Regulatory Policy	Dominika Misztela Senior Director Regulatory Policy Europe	Bill Speir Senior Director Advocacy and Regulatory Policy
Michelle Fransen Project Manager Health Initiatives	Michelle Mason Coordinator Global Regulatory Policy/ QSEAL Administrator
Public Affairs, Europe
Maarten Van Baelen Executive Director Europe	Karl Petrovsky Director Health Policy	Sándor Tóth Senior Manager Government Affairs and Health Policy
Athina Giannoutsou Manager Public Affairs	Melanie Conrads Office Manager
Public Affairs, North America
Julie Birkofer Senior Vice President Public Affairs	Tom Lilburn Senior Director Government Relations	Mat Gulick Director Global Communications
Rachel Liebe Manager Global Communications	Tim Swope Manager Government Relations	Manisha Vasudeva Communications Specialist Global Communications
	April O'Neal Executive Assistant
Finance & Operations
Gene Stroshane Senior Director Finances & Operations	Cathy Izzi Senior Director Human Resources & Administrative Services	Mike McCormick Director IT & Facilities
	Charon Smith Senior Manager Accounts Receivables/Payables

PPTA News

Inception Impact Assessment Underlines the Need for Timely Action to Decrease the Reliance on Third Countries for Plasma +

The Plasma Protein Therapeutics Association (PPTA) welcomes the European Commission’s publication of the Inception Impact Assessment (IIA) as a necessary step in the ongoing evaluation of the EU legislation on blood, tissues, and cells (BTC). Rightfully, the assessment underlines the need for timely action to decrease Europe’s reliance on third countries for plasma. We appeal to authorities to urgently take the necessary steps to collect more plasma through plasmapheresis in Europe As highlighted by the European Commission, plasmapheresis is a more efficient collection method compared to the collection of recovered plasma.¹
Read More
PPTA Statement on the Urgent Need for Plasma Donation +

COVID-19 continues to present a prolonged, global public health emergency, but PPTA remains steadfastly committed to its mission to promote the availability of — and access to — safe and effective plasma protein therapies for all patients. PPTA member companies operate more than 1,000 Source plasma donation centers in the U.S. and four countries in the European Union and manufacture plasma-derived therapies that treat patients with serious, rare, and often genetic diseases and disorders, including: primary immune deficiencies, bleeding disorders, Alpha-1 Antitrypsin deficiency, hereditary angioedema, and certain neurological conditions. These conditions are often only treated with therapies produced from plasma.
Read More
Plasma Donors Should be Celebrated, not Denigrated +

The Guardian published an editorial on October 21 by Arwa Mahdawi that relies heavily on a 2015 article that intentionally sought to perpetuate a divisive representation of plasma donors’ commitments and motivations – Ms. Mahdawi used those negative insinuations in a broader attempt to castigate the U.S. and its public support programs. The Plasma Protein Therapeutics Association (PPTA) and its member companies are grateful for every plasma donor, each of whom directly contributes to saving and improving the lives of people facing serious, inherited, and life-threatening diseases.
Read More
International Plasma Awareness Week 2020: Be a Hero, Donate Plasma Today +

ANNAPOLIS, MD (October 5, 2020) — The Plasma Protein Therapeutics Association (PPTA) is proud to mark the launch of the eighth annual International Plasma Awareness Week (IPAW), which will run until October 9.
Read More

1
2
3

› ‹

Mission Video

Learn more about the need for plasma donors, plasma donation, and how you can save and improve lives. Find a Donation Center.

"How Is Your Day?" is an initiative to raise awareness of the unique nature of plasma protein therapies and the value they provide to patients. It aims to inform and educate decision makers and the general public worldwide.

Get involved and follow "How Is Your Day?" on social media @HIYDglobal

Media and Information

Advocacy

Copyright © 2020 PPTA. All rights reserved. (202) 789-3100

Terms of Use | Privacy Statement | Sitemap